Prevalence and geographical variation of dementia in New Zealand from 2012 to 2015: Brief report utilising routinely collected data within the Integrated Data Infrastructure.


Journal

Australasian journal on ageing
ISSN: 1741-6612
Titre abrégé: Australas J Ageing
Pays: Australia
ID NLM: 9808874

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 20 06 2019
revised: 17 02 2020
accepted: 18 02 2020
pubmed: 13 5 2020
medline: 25 6 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

There are no national dementia epidemiological studies using New Zealand (NZ) data. NZ routinely collects health-care data within the Integrated Data Infrastructure (IDI). The study objectives were to 1) investigate late-onset dementia estimates using the IDI between 2012-2015 and compare these with 2) published estimates, and 3) variations between North and South Islands and ethnicity. A population-based, retrospective cohort design was applied to routinely collected de-identified health/administrative IDI data. Dementia was defined by ICD-10-AM dementia codes or anti-dementia drugs. Approximately 2% of those aged ≥60 years had dementia, lower than published estimates. Dementia was higher in North Island; in 80- to 89-year-olds; among the Māori population when age-standardised, and 9% of all dementia cases had >1 dementia sub-type. To our knowledge, this is the first study ascertaining dementia estimates using NZ's whole-of-population IDI data. Estimates were lower than existing NZ estimates, for several reasons. Further work is required, including expanding IDI data sets, to develop future estimates that better reflect NZ's diverse population.

Identifiants

pubmed: 32394527
doi: 10.1111/ajag.12790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-304

Subventions

Organisme : Medical Research Council (MRC) UK
ID : MR/ L501530/1 MR/K02992/1
Organisme : Medical Research Council (MRC) UK
ID : MR/K02992/1
Organisme : Medical Research Council Supplementary Travel Grant
Organisme : Alzheimer Scotland
ID : R44394
Organisme : Biotechnology and Biological Sciences Research Council
ID : MR/ L501530/1 MR/K02992/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : MR/K02992/1
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Australasian Journal on Ageing published by John Wiley & Sons Australia, Ltd on behalf of AJA Inc.

Références

Prince M, Guerchet M, Prina M. Alzheimer's Disease International: Policy Brief for Heads of Government, The Global Impact of Dementia 2013-2050. London: Alzheimer's Disease International; 2013.
Tobias M, Yeh LC, Johnson E. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031. Aust N Z J Psychiatry. 2008;42(9):828-836.
Deloitte Access Economics. Updated Dementia Economic Impact Report, 2011, New Zealand, Alzheimers New Zealand. 2012:i-32. http://www.alzheimers.org.nz/getattachment/News-Info/New-Zealand-data/Updated_Dementia_Economic_Impact_Report_2012_New_Zealand.pdf/. Accessed March 5, 2020.
Deloitte and Alzheimers New Zealand. Dementia Economic Impact Report, 2016; 2016: 1-78. https://www.alzheimers.org.nz/getmedia/79f7fd09-93fe-43b0-a837-771027bb23c0/Economic-Impacts-of-Dementia-2017.pdf/. Accessed March 5, 2020.
Kerse N, Lapsley H, Moyes S, Zawaly K, Hayman K. LiLACS NZ. 2017. Dementia: supplementary findings from LiLACS NZ for Section Five, ‘Service Use and Common Health Conditions’ in the report ‘Health, Independence and Caregiving in Advanced Age’. Auckland. In: LiLACS NZ, School of Population Health, ed. The University of Auckland; 2017. https://www.fmhs.auckland.ac.nz/en/faculty/lilacs/research/publications.html. Accessed March 5, 2020.
Teh R, Kerse N, Kepa M et al. Self-rated health, health-related behaviours and medical conditions of Maori and non-Maori in advanced age: LiLACS NZ. N Z Med J. 2014;127(1397):13-29.
Russ TC, Murianni L, Icaza G, Slachevsky A, Starr JM. Geographical variation in dementia mortality in Italy, New Zealand, and Chile: the impact of latitude, vitamin D, and air pollution. Dement Geriatr Cogn Disord. 2016;42(1-2):31-41.
Russ TC, Gatz M, Pedersen NL et al. Geographical variation in dementia: examining the role of environmental factors in Sweden and Scotland. Epidemiology. 2015;26(2):263-270.
Statistics New Zealand. Integrated Data Infrastructure; 2018. https://www.stats.govt.nz/integrated-data/integrated-data-infrastructure/. Accessed March 5, 2020.
Sommerlad A, Perera G, Singh-Manoux A, Lewis G, Stewart R, Livingston G. Accuracy of general hospital dementia diagnoses in England: Sensitivity, specificity, and predictors of diagnostic accuracy 2008-2016. Alzheimers Dement. 2018;14(7):933-943.
Brown A, Kirichek O, Balkwill A et al. Comparison of dementia recorded in routinely collected hospital admission data in England with dementia recorded in primary care. Emerg Themes Epidemiol. 2016;13:11.
Pujades-Rodriguez M, Assi V, Gonzalez-Izquierdo A et al. The diagnosis, burden and prognosis of dementia: a record-linkage cohort study in England. PLoS ONE. 2018;13(6):e0199026.
Ministry of Health New Zealand. HISO 10001:2017 Ethnicity Data Protocols. Wellington; 2017. https://www.health.govt.nz/publication/hiso-100012017-ethnicity-data-protocols. Accessed March 5, 2020.
Teng A, Gibb S, Sporle A. Ethnicity in the IDI; 2017 [cited 2019 18th June]. https://vhin.co.nz/guides/ethnicity-and-the-idi/. Accessed March 5, 2020.
Statistics New Zealand. Microdata Output Guide; 2016. http://archive.stats.govt.nz/~/media/Statistics/services/microdata-access/data-lab/microdata-output-guide-2016.pdf. Accessed March 5, 2020.
Statistics New Zealand. Standards; 2019. http://archive.stats.govt.nz/browse_for_stats/Maps_and_geography/Geographic-areas/urban-ruralprofile/standards.aspx. Accessed March 5, 2020.
Benchimol EI, Smeeth L, Guttmann A et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.
Grandal Leiros B, Pérez Méndez LI, Zelaya Huerta MV et al. Prevalence and concordance between the clinical and the post-mortem diagnosis of dementia in a psychogeriatric clinic. Neurologia. 2018;33(1):13-17.
Cullum S, Mullin K, Zeng I et al. Do community-dwelling Maori and Pacific peoples present with dementia at a younger age and at a later stage compared with NZ Europeans? Int J Geriatr Psychiatry. 2018;33(8):1098-1104.
Stone C, Copeland B, Collier C, Cheung G. Memory clinic survey in New Zealand: a second look. Australas Psychiatry. 2019;27(5):486-490.
Norris P, Horsburgh S, Lovelock K et al. Medicalisation or under-treatment? Psychotropic medication use by elderly people in New Zealand. Health Sociol Rev. 2011;20(2):202-218.
Payman V, Yates S, Cullum S. Early onset dementia in New Zealand Pacific boxers: a case series. N Z Med J. 2018;131(1474):20-26.
Dyall L. Dementia: continuation of health and ethnic inequalities in New Zealand. N Z Med J. 2014;127(1389):68-80.
Alzheimer's Disease International. Alzheimer's Disease International World Alzheimer Report 2019: Attitudes to dementia. London: Alzheimer’s Disease International (ADI);2019. https://www.alz.co.uk/research/WorldAlzheimerReport2019.pdf. Accessed March 5, 2020.
Dudley M, Menzies O, Elder H, Nathan L, Garrett N, Wilson D. Mate wareware : Understanding ‘dementia’ from a Māori perspective. N Z Med J.2019;132(1503):66-74.
Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M. World Alzheimer Report 2016: Improving healthcare for people living with dementia. Coverage, Quality and Costs now and in the future. London: Alzheimer's Disease International (ADI):2016. https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf. Accessed March 5, 2020.
Dementia Intelligence Network. Dementia Partnerships. https://dementiapartnerships.com/resource/the-dementia-profile/. Accessed March 5, 2020.
Technical Advisory Services (TAS) Kahui Tuitui Tangata and interRAI New Zealand. National interRAI Data Analysis Annual Report 2015/16; 2017. https://tas.health.nz/assets/interRAI/2015-16-National-interRAI-Data-Analysis-Annual-Report.pdf. Accessed March 5, 2020.
Ministry of Health New Zealand. New Zealand Framework for Dementia Care. Wellington: Ministry of Health New Zealand; 2013:i-49.
Wilkinson T, Ly A, Schnier C et al. Identifying dementia cases with routinely collected health data: a systematic review. Alzheimers Dement. 2018;14(8):1038-1051.
Waller M, Mishra GD, Dobson AJ. Estimating the prevalence of dementia using multiple linked administrative health records and capture-recapture methodology. Emerg Themes Epidemiol. 2017;14:3.
Francesconi P, Gini R, Roti L, Bartolacci S, Corsi A, Buiatti E. The Tuscany experimental registry for Alzheimer's disease and other dementias: how many demented people does it capture? Aging Clin Exp Res. 2007;19(5):390-393.
van de Vorst IE, Vaartjes I, Sinnecker LF, Beks LJM, Bots ML, Koek HL. The validity of national hospital discharge register data on dementia: a comparative analysis using clinical data from a university medical centre. Neth J Med. 2015;73(2):69-75.
Russ TC, Parra MA, Lim AE, Law E, Connelly PJ, Starr JM. Prediction of general hospital admission in people with dementia: cohort study. Br J Psychiatry. 2015;206:153-159.
Sibbett RA, Russ TC, Deary IJ, Starr JM. Dementia ascertainment using existing data in UK longitudinal and cohort studies: a systematic review of methodology. BMC Psychiatry. 2017;17(1):239.

Auteurs

Katherine Elizabeth Walesby (KE)

Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.

Daniel John Exeter (DJ)

Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.

Sheree Gibb (S)

Department of Public Health, University of Otago, Wellington, New Zealand.

Philip Clive Wood (PC)

North Shore Hospital, Auckland, New Zealand.
Auckland Dementia Prevention Research Clinic, Auckland, New Zealand.
Healthy Ageing, Ministry of Health New Zealand, Wellington, New Zealand.

John Michael Starr (JM)

Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
Western General Hospital, NHS Lothian, Edinburgh, UK.

Tom Charles Russ (TC)

Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
NHS Lothian, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH